Guangdong, China

Zhongmin Maxwell Wang

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Zhongshan, CN (2019 - 2024)
  • Guangdong, CN (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):

Title: Innovations and Contributions of Zhongmin Maxwell Wang in Immunology

Introduction: Zhongmin Maxwell Wang is a prominent inventor located in Guangdong, China. With an impressive portfolio of 14 patents, Wang has made significant strides in the fields of immunology and tumor treatment. His inventions focus on developing innovative therapeutic antibodies that can have a profound impact on the treatment of various diseases.

Latest Patents: Among his latest innovations, Wang has developed the "Anti-IL-1β antibody and pharmaceutical composition thereof and use of same." This invention relates to an anti-IL-1β antibody that effectively binds to human IL-1β, inhibiting its interaction with the IL-1 receptor (IL-1R1). This technology holds great promise for the development of medications aimed at preventing and treating autoimmune diseases, including systemic juvenile idiopathic arthritis, gouty arthritis, and even certain cancers. Another significant patent is the "Anti-PD-1/VEGFA bifunctional antibody, pharmaceutical composition thereof and use thereof." This bifunctional antibody targets both VEGFA and PD-1, addressing immune suppression within the body and potentially reducing tumor-induced angiogenesis.

Career Highlights: Zhongmin Maxwell Wang has contributed his expertise to various esteemed companies, notably Akeso Biopharma, Inc. and Ad Pharmaceutical Co., Inc. His role in these organizations has enabled him to advance his research and focus on groundbreaking inventions.

Collaborations: Collaboration is fundamental to innovation in the scientific field. Wang has worked alongside notable colleagues, including Baiyong Li and Yu Xia. These partnerships have been instrumental in furthering research endeavors and arriving at effective solutions for complex medical challenges.

Conclusion: Zhongmin Maxwell Wang’s contributions to the field of immunology and tumor treatment are notable. His innovative patents, coupled with collaborations at leading biopharmaceutical companies, showcase his commitment to advancing medical science. As he continues to push the boundaries of innovation with his inventions, the potential benefits for patients and the healthcare industry are immense.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…